HIGHLIGHTS
- who: CFTR et al. from the University of Alabama at Birmingham, United States have published the article: Post-approval studies with the CFTR modulators Elexacaftor- Tezacaftor u2014 Ivacaftor, in the Journal: (JOURNAL)
SUMMARY
Assays for quantifying ELX, TEZ, IVA in human plasma and cell lysate have meanwhile been established by academic labs applying multiple reaction monitoring mass spectrometry (MRM/MS) (Reyes-Ortega et_al, 2020) or isotope dilution liquid chromatography tandem mass spectrometry (LC-MS/MS) (Habler et_al, 2021; Ryan et_al, 2022). Meanwhile numerous adverse skin reactions have been observed in the real-life . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.